Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Long-term renal outcome in methylmalonic acidemia in adolescents and adults

Fig. 2

Measured GFR by clearance of iohexol. a Measured GFR (mL/min/1.73 m2) according to biochemical phenotype. Medians. b Patients (n) by CKD stage according to KDIGO stages: stage 1, GFR > 90 mL/min/1.73 m2; stage 2, GFR between 60 and 90 mL/min/1.73 m2; stage 3a, GFR between 45 and 60 mL/min/1.73 m2; stage 3b, GFR between 30 and 45 mL/min/1.73 m2; stage 4, GFR between 30 and 45 mL/min/1.73 m2. c Measured GFR (mL/min/1.73 m2) according to protein intake (g/day). d Measured GFR (mL/min/1.73 m2) according to vitamin B12 responsiveness. Medians ± interquartile ranges. Abbreviations: CKD, chronic kidney disease; GFR, glomerular filtration rate

Back to article page